Stryker buys Israeli brain stent maker for $135M
Editorial Staff | October 17, 2012 | Cardiovascular Business | Vascular & Endovascular

Stryker has signed a definitive agreement to acquire privately held Surpass Medical in an all-cash transaction for $100 million and up to an additional $35 million in milestone payments.

Founded in 2005 and headquartered in Tel Aviv, Israel, with manufacturing and R&D in Miramar, Fla., Surpass is seeking to develop and commercialize flow diversion stent technology to treat brain aneurysms using a mesh design and delivery system.  

Surpass said its NeuroEndoGraft family uses flow diverters, which are designed to redirect blood flow away from an aneurysm, allowing a stable clot to be formed within the aneurysm pouch. The NeuroEndoGraft has CE Mark with a limited launch underway outside the U.S. In addition, the company will begin enrolling patients in an Investigational Device Exemption clinical trial in the fourth quarter.

The closing of the transaction is subject to customary closing conditions. Upon closing, the transaction is expected to be neutral to Stryker's 2012 earnings per share excluding acquisition and integration-related charges. The transaction is expected to close in the fourth quarter.

Editorial Staff

Related Content

Boston Scientific recalls premixed embolic agent after two deaths
Anemia may help explain why women are more likely to die during heart bypass surgery
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
GE Healthcare launching new AI software for handheld ultrasound system
New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup